Publications by authors named "Frank Smeele"
Article Synopsis
- Researchers found it tough to give heart failure patients the best medications, even though there are guidelines.
- In 2021, a group called the European Heart Failure Association created patient profiles based on their health traits to help tailor treatments better.
- They studied 4,455 heart failure patients and discovered that almost 40% could fit into these profiles, which could lead to better and more personalized treatments.
Background: Atrial fibrillation (AF) is common in chronic heart failure (HF) patients and influences the choice and effects of drug and device therapy. In this large real-world HF registry, we studied whether the presence of AF affects the prescription of guideline-recommended HF therapy.
Methods: We analyzed 8253 patients with chronic HF with reduced ejection fraction (HFrEF) from 34 Dutch outpatient clinics included in the period between 2013 and 2016 treated according to the 2012 ESC guidelines.
Objectives: This study investigated adherence to drug therapy guidelines in heart failure (HF) with reduced left-ventricular ejection fraction (LVEF) of <40% (heart failure with reduced ejection fraction [HFrEF]), in which evidence-based treatment has been established.
Background: Despite previous surveys of HF, important uncertainties remain regarding guideline adherence in a representative real-world population.
Methods: A cross-sectional registry in 34 Dutch HF outpatient clinics that included 10,910 patients with the diagnosis of HF was examined.
Background: Long-term continuous electrocardiographic monitoring shows a substantial prevalence of asymptomatic, subclinical atrial fibrillation (SCAF) in patients with pacemakers and patients with cryptogenic stroke. Whether SCAF is also common in other patients without these conditions is unknown.
Methods: We implanted subcutaneous electrocardiographic monitors (St.